skip to main | skip to sidebar

Equity : Indian-commodity.com

Wednesday, November 28, 2007

Zenotech Laboratories Allots Equity Shares

Ranbaxy Laboratories has announced that Zenotech Laboratories (Zenotech) has allotted 54,89,536 equity shares of Rs 10 each at a premium of Rs 150 per share for cash to Ranbaxy Laboratories on preferential basis on 23 November 2007. Intimation from Zenotech regarding allotment of the aforesaid shares has been received by the company on 26 November 2007.

The company made this announcement during the trading hours today, 27 November 2007.
Posted by Indian-commodity at 11:11 AM

No comments:

Post a Comment

Newer Post Older Post Home
Subscribe to: Post Comments (Atom)
..

No. Of Visitors

Free Listing Of Blogs



Online Suggestions

mexican zithromax

Blog Archive

  • August (3)
  • July (77)
  • June (74)
  • May (47)
  • April (54)
  • March (43)
  • February (25)
  • January (34)
  • December (84)
  • November (95)
  • October (36)
  • September (45)
  • August (37)
  • July (47)
  • June (33)
  • May (30)
  • April (90)
  • March (84)
  • February (102)
  • January (112)
  • December (84)
  • November (96)
  • October (81)
  • September (40)
  • August (45)
  • July (39)
  • June (34)
  • May (29)
  • April (28)
  • March (51)
  • February (41)
  • January (26)
  • December (6)

More Informative Links

More About Market

  • Equity News(Current Blog)
  • Stock Market
  • Shares Rate
  • Online Trading
  • Mutual Fund
  • IPO Info
  • Investment
  • Economy News
  • E-Broking
  • Depository Participants
  • Corporate News
  • Company's Review Reports
  • Commodity News
  • Commodity Market
  • Board Meeting

Disclaimer

By clicking on this blog you accept all the terms and conditions framed by us. News made available here are for informational purpose only. While utmost care has been taken in providing the same. We claim no responsibility for its accuracy. Readers of this blog who make their decision based on the information posted here are solely responsible for their actions and we request them to study all aspects before taking decisions.